335349-57-0

Basic information

• Product Name: 5-chloro-4-iodo-2-nitroaniline
• Synonyms: 5-Chloro-4-iodo-2-nitrophenylamine;5-chloro-4-iodo-2-nitroaniline;5-chloro-4-iodo-2-nitrobenzenaMine
• CAS NO: 335349-57-0
• Molecular Formula: C₆H₄ClIN₂O₂
• Molecular Weight: 298
• EINECS: -0
• Mol File: 335349-57-0.mol
• Article Data: 18

Chemical Properties

• Boiling Point: 389.7±42.0 °C(Predicted)
• Appearance: /
• Density: 2.169
• Storage Temp.: 2-8°C(protect from light)
• PKA: -2.43±0.25(Predicted)
• CAS DataBase Reference: 5-chloro-4-iodo-2-nitroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 5-chloro-4-iodo-2-nitroaniline(335349-57-0)
• EPA Substance Registry System: 5-chloro-4-iodo-2-nitroaniline(335349-57-0)

Safety Data

• Hazardous Substances Data: 335349-57-0(Hazardous Substances Data)

Usage

General Description

5-chloro-4-iodo-2-nitroaniline is a chemical compound with the molecular formula C6H4ClIN2O2. It is a nitroaniline derivative, which means it contains a nitro group (-NO2) and an aniline group (-NH2). It is also halogenated, with chlorine and iodine substituents. 5-chloro-4-iodo-2-nitroaniline is commonly used in organic synthesis and pharmaceutical research as a building block for more complex molecules. It is important to handle this compound with caution, as it may have hazardous properties and should be stored and used in a designated laboratory setting following appropriate safety protocols.

Upstream product

• 1635-61-6 5-chloro-2-nitroaniline 

Downstream Products

• 335349-68-3 4-iodo-5-(2-methoxy-ethoxy)-2-nitro-phenylamine 
• 335349-66-1 4-iodo-5-methoxy-2-nitroaniline 
• 335349-60-5 (5-chloro-4-iodo-2-nitro-phenyl)-carbamic acid tert-butyl ester 
• 335349-76-3 5-(2-tert.-butoxy-ethoxy)-4-iodo-2-nitro-phenylamine 
• 335349-94-5 (RS)-5-(2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-4-iodo-2-nitro-phenylamine 
• 473547-08-9 [4-iodo-2-nitro-5-(2,2,2-trifluoro-ethoxy)-phenyl]-carbamic acid tert.-butyl ester 
• 1219739-36-2 5-((6-chloro-5-(1-methyl-1H-indol-5-yl)-1H-benzo[d]-imidazol-2-yl)oxy)-2-methylbenzoic acid 
• 1219737-12-8 5-((5-([1,1'-biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic acid 
• 1219741-39-5 methyl 5-[(6-chloro-5-iodo-1-{[2-(trimethylsilyl)ethoxy]-methyl}-1H-benzimidazol-2-yl)oxy]-2-methylbenzoate 
• 1219737-74-2 3-((5-([1,1'-biphenyl]-4-yl)-6-chloro-1Hbenzo[d]imidazol-2-yl)thio)benzoic acid 

Relevant articles and documents

Compound with AMPK agonistic activity and preparation and application of prodrug thereof

The invention relates to a compound with AMPK agonistic activity and a prodrug thereof, and as well as a preparation method and medical application of a prodrug thereof. The compound has the structure shown in the formula (I), and the prodrug of the compound has the structure shown in the formula (II), wherein each group and the substituent are as defined in the specification. The invention discloses a preparation method of the compound and application of the compound in prevention and treatment AMPK related diseases, and the AMPK related diseases include, but are not limited to, energy metabolism abnormality related diseases. Neurodegenerative diseases and inflammation-related diseases and the like.

Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase

5′-Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of mammalian energy homeostasis and has been implicated in mediating many of the beneficial effects of exercise and weight loss including lipid and glucose trafficking. As such,

SUBSTITUTED HETEROARYLBENZIMIDAZOLE COMPOUNDS

The present invention covers substituted heteroarylbenzimidazole compounds of general formula (I) : in which R1, R2, R3, R4, R5, R6a and R6b are as defined herein, methods of pre